Conditions
Your brain. Your specific targets.
TGA Approved — Depression
01
Treatment-Resistant Depression
For patients who have not responded to ≥2 antidepressants at therapeutic doses. High-frequency rTMS to the left DLPFC is the TGA-approved protocol, with neuronavigation improving target accuracy and potentially treatment outcomes.
Off-Label
02
PTSD & Trauma-Related Disorders
Emerging evidence supports rTMS targeting of the DLPFC and right ventrolateral PFC in PTSD. Neuronavigation allows individualised protocol selection — LF right or HF left — based on symptom profile and clinical assessment.
Off-Label
03
Chronic Pain & Fibromyalgia
rTMS over the motor cortex (M1) and DLPFC has demonstrated analgesic effects in neuropathic pain and fibromyalgia. A 2022 RCT showed 66.6% of fibromyalgia patients achieved ≥30% pain reduction with DLPFC-targeted rTMS.
Off-Label
05
Anxiety Disorders
Low-frequency rTMS to the right DLPFC has anxiolytic effects supported by multiple RCTs. Often used in conjunction with depression treatment given high comorbidity rates. Protocol selection individualised to symptom presentation.
Off-Label
02
PTSD & Trauma-Related Disorders
Emerging evidence supports rTMS targeting of the DLPFC and right ventrolateral PFC in PTSD. Neuronavigation allows individualised protocol selection — LF right or HF left — based on symptom profile and clinical assessment.
Off-Label
04
Brain Fog & Cognitive Fatigue
Prefrontal rTMS has been shown to improve processing speed, working memory, and cognitive endurance in Long COVID, post-concussion syndrome, and treatment-resistant depression. Neuronavigation ensures frontal circuits are accurately engaged.
Off-Label
05
Anxiety Disorders
Low-frequency rTMS to the right DLPFC has anxiolytic effects supported by multiple RCTs. Often used in conjunction with depression treatment given high comorbidity rates. Protocol selection individualised to symptom presentation.
Investigational — tDCS
06
Mood, Cognition & Neurological Conditions
tDCS is offered as an investigational treatment under psychiatrist oversight. Applications under evaluation include depression augmentation, cognitive rehabilitation, and pain modulation. Home-based protocols available.